Among these hormones, Peptide-YY (PYY) and Glucagon-like-peptide-1 (GLP-1) are of specific interest in the field of obesity and diabetes as they have been implicated in the regulation of food intake and insulin secretion, even though their precise physiological significance in healthy and pathological states is still debated1–6. This evidence concerns the gene PYY and obesity disorder.